|
Gustav Christensen joined Dyax as our Executive Vice President and Chief Business Officer in April 2007. He oversees and leads the Company’s partnering strategy as well as other business development activities such as licensing and collaboration transactions. Previously, Mr. Christensen was Managing Director of Apeiron Partners, LLC, a boutique life sciences investment bank, from 2005 -2007. He began his career as General Manager at Baxter Travenol Laboratories and left in 1983 to become the Vice President of Business Development at Genetics Institute Inc. from 1983-1988. Additionally, he has been the CEO or senior manager of seven biopharmaceutical firms. He currently serves on the Board of Alantos Pharmaceuticals and on the Advisory Boards for two venture funds. Mr. Christensen received his master’s of science degree in economics from the University of Aarhus (Denmark) and a master’s degree in business administration (MBA) from Harvard Business School. | 